Clinical Trials Browser

Neoplasms × Trabectedin × Clear all

NCT01453283 2017-07-02

Tabectedin to Treat Children and Adolescents With Cancer

Phase 1 Completed

CNSGastrointestinalGenitourinarySarcoma

Brain Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

NCT00060944 2014-09-08

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Phase 2 Completed

271 enrolled 13 charts

Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Neoplasms

NCT00786838 2014-04-11

A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

Phase 2 Completed

76 enrolled 17 charts

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT00050414 2013-01-10

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Phase 2 Completed

Adnexal Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms

NCT00102609 2013-01-10

A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma

Phase 1 Completed

Neoplasms, Neoplasms by Histologic Type, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT00050440 2013-01-08

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Phase 2 Completed

Carcinoma, Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Phase 2 Completed

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases